Inventor · disambiguated record
Niv Papo
Also filed as: PAPO NIV
7 granted patents·6 pending applications·23 citations·filing 2000–2023
82Inventor score
Files withUNIV LELAND STANFORD JUNIOR7NAT INST BIOTECHNOLOGY NEGEV LTD4COCHRAN JENNIFER R1YISSUM RES DEV CO1
Top patents by PatentIndex Score
13 records- 0182US8741839B2Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrinCOCHRAN JENNIFER R·Filed 2010·Granted Jun 3, 2014·5 cites·12 claims
- 0280US9441026B2Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrinUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Sep 13, 2016·3 cites·4 claims
- 0378US9234021B2Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrinUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Jan 12, 2016·2 cites·2 claims
- 0478US6323365B1Active derivative of valproic acid for the treatment of neurological and psychotic disorders and a method for their preparationYISSUM RES DEV CO·Filed 2000·Granted Nov 27, 2001·10 cites·12 claims
- 0577US11098091B2Compositions and methods for treatment of bone associated diseasesNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2017·Granted Aug 24, 2021·2 cites·7 claims
- 0673US9505822B2Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrinUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Nov 29, 2016·1 cites·9 claims
- 0765US11976099B2Compositions and methods for treatment of bone associated diseasesNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2021·Granted May 7, 2024·0 cites·8 claims
- 0862US2015005235A1Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 IntegrinUNIV LELAND STANFORD JUNIOR·Filed 2014·Application pending·0 cites
- 0959US2025206843A1Binding molecules specific to human epidermal growth factor receptor 2NAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2023·Application pending·0 cites
- 1055US2019048051A1Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha v beta 3 integrinUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
- 1151US2016039896A1Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha v beta 3 integrinUNIV LELAND STANFORD JUNIOR·Filed 2015·Application pending·0 cites
- 1239US2018362616A1VARIANTS OF AMYLOID beta-PROTEIN PRECURSOR INHIBITOR DOMAINNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2016·Application pending·0 cites
- 1337US2016039895A1Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha v beta 3 integrinUNIV LELAND STANFORD JUNIOR·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Niv Papo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →